Inlybest 1/5 mg (Axitinib) is known for selectively inhibiting the proliferation processes of cancer cells which include angiogenesis (formation of new blood vessels), growth and metastases (spread) of these cells. Inlybest 1/5mg (Axitinib) gets immediately absorbed in the system in between 2.5 to 4.1 hours.